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Medical University, Dalian and 5) Shenzhen Puensum Genetech Institution, Shenzhen, ChinaAbstractAcute cholecystitis (AC) is one of the most common surgical diseases. Bacterial infection accounts for 50% to 85% of the disease’s onset.
Since there is a close relationship between the biliary system and the gut, the aims of this study were to characterize and determine the
inﬂuence of gut microbiota on AC, to detect the pathogenic microorganism in the biliary system, and to explore the relationship
between the gut and bile microbiota of patients with AC. A total of 185 713 high-quality sequence reads were generated from the faecal
samples of 15 patients and 13 healthy controls by 16S rRNA gene pyrosequencing. Patients’ samples were signiﬁcantly enriched in
Akkermansia, Enterobacter and Escherichia/Shigella group. The healthy controls, however, showed signiﬁcant enrichment of Clostridiales,
Coprococcus, Coprobacillaceae, Paraprevotella, Turicibacter and TM7-3 in their faecal samples. Escherichia coli was the main biliary pathogenic
microorganism, among others such as Klebsiella spp., Clostridium perfringens, Citrobacter freundii and Enterobacter cloacae in the bile of the
patients. Additionally, the amount of bile endotoxin signiﬁcantly correlated with the number of Enterobacteriaceae, especially E. coli. Our
data indicate that Enterobacteriaceae might play essential role in the pathogenesis and/or progress of AC. This was veriﬁed in an in vivo
model using a pathogenic E. coli isolated from one of the patients in guinea pigs and observed marked gallbladder inﬂammation and
morphologic changes. This study thus provides insight which could be useful for the prevention, diagnosis and treatment of AC and
related diseases by controlling the growth of Enterobacteriaceae to alleviate the infection.
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should be considered ﬁrst author.IntroductionAcute cholecystitis (AC), a sudden onset of inﬂammation of the
gallbladder that causes severe abdominal pain, is increasinglyClinical Microbiology and Infection © 2015 European Society of Cbecoming common, at a current prevalence of 5% to 10% in
the elderly [1,2]. More than 90% of AC is caused by choleli-
thiasis [3], and the remaining acalculous cholecystitis is gener-
ally associated with trauma, parenteral nutrition or sepsis
[4–6].
Recent studies suggested bacterial infection in the biliary
system to play an important role in the aetiology of cholecystitis
[7,8]. Diverse bacterial ﬂora in the bile and on the walls of the
gallbladder of patients with cholecystitis were observed, iso-
lated and characterized through microorganism culture tech-
niques [9–11]. The most frequent pathogens in biliary infection
are Gram-negative anaerobes, dominated by Escherichia coli,
Klebsiella spp., Acinetobacter baumannii complex and Enterobacter
spp. [12,13].Clin Microbiol Infect 2015; 21: 851.e1–851.e9
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
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851.e2 Clinical Microbiology and Infection, Volume 21 Number 9, September 2015 CMIIntriguingly, a potential relationship between the gut ﬂora
and AC was also observed [13,14]. Gut microbes play regu-
lating roles in bile acid metabolism as well as gallstone forma-
tion [15,16] and contributes to inﬂammatory responses. A
hypothesis prevails that gut pathogens might enter the biliary
tract by two paths: the ascending route through the gastroin-
testinal tract or the hematogenous route via the portal vein
blood [17,18].
In this study, we investigated the gut and bile microbiota of a
group of AC patients by using three techniques, pyrosequenc-
ing of 16S rRNA gene, denaturing gradient gel electrophoresis
(DGGE) and quantitative PCR (qPCR) analysis. It was found
that Enterobacteriaceae was the main organism in the patients
of gut microbial dysbiosis and bile infection. Their bile endo-
toxin levels, as well as in vivo E. coli feeding experiment using
guinea pigs, conﬁrmed the observation. In addition, there was
high consistency of Enterobacteriaceae counts between the gut
and bile samples which suggested gut-originated pathogens to
be responsible for the bile infection.Materials and methodsStudy subjects and sample collection
Subjects were recruited, and diagnosis by color Doppler ul-
trasonography for hepatobiliary diseases was conducted at the
First and Second Afﬁliated Hospitals of Dalian Medical Uni-
versity of China. A total of 25 patients (including 20 cases of
AC, four acute cholangitis cases, and one case of both diseases)
and 13 healthy control subjects aged 38 to 79 years participated
in this study. None of the subjects (including healthy controls)
had any history of gastrointestinal tract disorder or took either
antibiotics or probiotics within 8 weeks before sampling.
However, most patients were diagnosed with common com-
plications, including gallstones (cholecystolithiasis, chol-
edocholith), obstructive jaundice and hepatic cyst. Detailed
clinical information of all patients is presented in Supplementary
Table S1. This study was approved by the Institutional Ethics
Committee for Research of Dalian Medical University.
To study the effect of AC on gut microbiota, 28 faecal
samples were collected from the AC patients (n = 15) and
healthy volunteers (n = 13). Faecal samples were collected in
sterile tubes at the hospitals and were immediately stored
at −80°C until processing and use for high-throughput 16S
rRNA gene pyrosequencing.
To characterize the biliary tract microbiota, 16 bile samples
were obtained from the AC patients during either percuta-
neous transhepatic cholangial drainage or percutaneous trans-
hepatic gallbladder drainage operation, and stored at −80°C.
For subsequent analysis, each sample was divided into fourClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectparts for qPCR, DGGE, endotoxin analysis and bacterial
culturing. Faecal samples of these patients were also collected
for qPCR analysis to reveal the relationship between gut and
bile ﬂora.
DNA extraction, 16S rRNA gene ampliﬁcation and
pyrosequencing
Total bacterial DNA was extracted according to the manufac-
turer’s instructions of QIAamp DNA Blood Mini Kit (Qiagen,
Germany). The quality of the nucleic acid was visually deter-
mined by electrophoresis on 1% agarose gel containing
ethidium bromide. The DNA concentration was measured
spectrophotometrically using BioPhotometer plus (NanoVue,
USA).
For 16S rRNA gene analysis, the V3 variable region was
ampliﬁed using the following primers, primer-F: 50-GC clamp
(CGCCCGGGGCGCGCCCCGGGCGGGGCGGGGGCAC-
GGGGGG)-CCTACGGGAGGCAGCAG-30; primer-R: 50-
ATTACCGCGGCTGCTGG-30. The GC clamp was attached
to the 50 end of the forward primer to allow detection of the
corresponding PCR products with DGGE [19]. PCR ampliﬁ-
cation was performed in an automated thermocycler (Thermo,
USA). After the reaction, the size of the obtained amplicon was
veriﬁed via electrophoresis. Pyrosequencing was performed on
a 454 CS FLX titanium sequencer (Roche 454 Life Science,
USA).
DGGE and sequence analysis
DGGE and sequence analysis were used to characterize the
dominant pathogens in bile. DGGE was performed by a Uni-
versal Mutation Detection System (Bio-Rad, USA); the method
was similar to what we previously reported [20] with slight
modiﬁcations. The electrophoresis with gradient of urea as well
as formamide ranged from 35% to 55% was run at 180 V for 10
minutes at 60°C, followed by ﬁxed voltage at 65 V for 7 hours.
The gels were stained in 0.5 μg/mL ethidium bromide solution
for 60 minutes, washed with deionized water, and viewed in a
Gel Documentation System (Bio-Rad, USA).
After this, DNA sequences of DGGE bands were cloned and
analysed. Speciﬁc bands were excised from polyacrylamide gel
under UV illumination, washed, and kept in 50 μL sterile water
at −20°C overnight. The extracted gel mix was incubated in a
90°C water bath for 10 minutes, and 4 μL of the solution was
taken and used as the DNA template for reampliﬁcation by
PCR using the original primers with GC clamp. After puriﬁca-
tion, the amplicons were ligated with the pMD18-T vector
(TaKaRa, Japan). The E. coli NovaBlue competent cells were
transformed by ligation reaction, and the positive colonies
carrying the plasmids with insertions were screened according
to blue–white selection. The recombinant plasmids wereious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 851.e1–851.e9
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3730XL DNA Analyzer (TaKaRa, Japan). For taxonomy
assignment, the obtained sequences were aligned to the non-
redundant nucleotides of the National Center for Biotech-
nology Information (NCBI-nt) by BLAST search [21].
Quantitative PCR
Real-time qPCR with group-speciﬁc primers was used to
quantify three important bacterial groups: Enterobacteriaceae,
Escherichia coli and Clostridium perfringens (Supplementary
Table S2, [22–24]). The qPCR reactions were performed in
25 μL volume according to the instruction of SYBRPremix Ex
Taq II (TliRNaseH Plus) (TaKaRa, Japan). Each reaction mixture
of 25 μL contained 12.5 μL of 2× SYBR Green PCR Mix, 9.1 μL
sterile deionized water, 1 μL of each primer (20 μM), 1 μL of
genomic DNA of samples and 0.4 μL ROX Reference Dye II.
The qPCR reactions were detected by Real-Time QPCR Sys-
tem (Agilent Technologies Stratagene Mx3005P, USA). For
Enterobacteriaceae, the ampliﬁcation parameters were set as
following: one cycle of 95°C for 1 minute, 40 cycles of 95°C for
5 seconds, 55°C for 30 seconds and 72°C for 30 seconds. For
E. coli, the parameters were as follows: one cycle of 95°C for 2
minutes, 40 cycles at 95°C for 15 seconds, 60°C for 20 seconds
and 72°C for 30 seconds. For C. perfringens, the parameters
were as follows: one cycle of 95°C for 5 minutes, 35 cycles at
95°C for 15 seconds, 55°C for 20 seconds and 72°C for 30
seconds. To obtain the melting curve, an extra cycle of 95°C
for 1 minute, 55°C for 30 seconds and 95°C for 30 seconds was
carried out. A tenfold dilution series of recombinant plasmids
containing the insert of interest was used in each real-time
qPCR assay to generate standard curves for absolute quantiﬁ-
cation of target DNA in test samples. The correlation coefﬁ-
cient values of the standard curves were limited from 0.99 to
1.0, and the ampliﬁcation efﬁciency was conﬁned between 90%
and 110%.
Endotoxins analysis
The Limulus Amebocyte Lysate (LAL) kit was used to quantify
the bacterial endotoxin, which refers to the lipopolysaccharide
level in the bile of AC patients. Brieﬂy, 50 μL bile samples and
50 μL LAL solutions were added in pyrogen-free microplate,
mixed and incubated for 10 minutes at 37°C; the chromogenic
substrate solution was added and incubated for 6 minutes at
37°C. The reaction was carried out according to the manu-
facturer’s protocol of pyrochrome LAL kit (Associates of Cape
Cod, USA) [25]. The reactants were checked under 545 nm
wavelength by a multimode plate reader (Perkin-Elmer, USA).
For endotoxin analysis, the odds ratio was calculated between
the Enterobacteriaceae or E. coli counts and the endotoxin
levels based on the logistic regression model.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InIsolation and identiﬁcation of E. coli strain in bile
To identify Enterobacteriaceae in AC, we attempted to isolate
the bacteria strains from the bile samples of these patients. For
bacteria proliferation, bile of 500 μL was added into 50 mL of
sterile Luria-Bertani liquid medium, and the culture was incu-
bated for 14 to 18 hours at 37°C. The culture was then spread
on Luria-Bertani solid agar to separate single colonies. A
pathogenic E. coli strain was isolated from one of the patients
(patient 9) which had a great quantity of Enterobacteriaceae. To
validate this strain, the bacterial genomic DNA was prepared by
EZNA Bacterial DNA Kit (Omega, USA), and the full-length
16S rRNA gene was sequenced by Sangon Biotech Ltd. The
obtained sequence was identiﬁed by aligning against the NCBI-
nt database using BLAST, which returned the best hit as E. coli
strain BW25113 genome (Supplementary Fig. S1a). The bac-
terial sample was also analysed by mass spectrometry (Ultra-
ﬂextreme MALDI-TOF/TOF MS), and the result showed the
bacterial sample was E. coli (Supplementary Fig. S1b). Twenty-
two kinds of E. coli single factor serum, Serotest E. coli (O&K)
Antisera (S&A Reagents Lab, Thailand), were used to imple-
ment the serotype identiﬁcation. The result showed that the
serotype of the pathogenic E. coli strain corresponded to
O124:K72, which belonged to enteroinvasive E. coli (EIEC).
Guinea pigs E. coli feeding experiment
Five 6-week-old male guinea pigs were obtained from the
speciﬁc-pathogen-free animal center at Dalian Medical Univer-
sity. They were randomly divided into two groups with free
access to normal food and water in a temperature-controlled
room with a 12:12 hour light–dark cycle and acclimatized for
a week before experimentation.
For the bacteria-treated groups, one guinea pig was orally
provided with the isolated E. coli strain at 1 × 108 colony-
forming units (CFU)/mL physiologic saline daily, and the other
two were given rectal suppositories containing 1 × 108 CFU of
the E. coli in 1 mL cocoa butter as the ground substance, ac-
cording to a previously described method [26]. After 30 days,
all the animals were dissected to collect organs, ﬁx tissue
samples and perform morphologic and histologic observation.
Hematoxylin and eosin (HE) staining was undertaken for organs
including gallbladder, liver, spleen, duodenum and colon. The
tissue preparations and examinations were carried out in the
pathology department of Dalian Medical University and read by
a pathologist who was blinded to the experimental design.
Statistical methods
Statistical analysis was implemented using the R platform
(v3.1.0). The relationship between two groups of samples was
characterized by the Pearson correlation coefﬁcient and was
visualized by the ggplot2 package [27]. Statistical signiﬁcancefectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 851.e1–851.e9
FIG. 1. Gut microbiota composition
differs between AC patients and
healthy controls. (a) Principal coordi-
nate analysis of unweighted Unifrac
distances. (b) Heat map constructed
using amount of signiﬁcantly different
genera. Colors represent increase or
decrease of each genus relative to
average level.
851.e4 Clinical Microbiology and Infection, Volume 21 Number 9, September 2015 CMIwas set at p < 0.05. For endotoxin level analysis, the odds ratio
was calculated by the logistic regression model.ResultsComparison of gut microbiota from AC patients with
healthy controls
To characterize the gut microbiota composition during AC, the
faecal samples of 15 patients and 13 healthy controls were
examined using 16S rRNA gene pyrosequencing. A total of
185 713 high-quality sequence reads were generated, with an
average of 6633 (±2453 SD) reads for each subject. All se-
quences were clustered into 9013 operational taxonomic units
based on 97% nucleotide similarity cutoff for species-level
bacterial phylotypes [28].Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectBiodiversity indexes were calculated to estimate the richness
and evenness of the microbial communities. The results showed
that the patients had signiﬁcantly lower Shannon index (p 0.03,
Student t test), Chao1 index (p 0.02), phylogenetic diversity (p
0.02) and observed number of species (p < 0.01), indicating gut
microbial dysbiosis in AC. Unifrac distance was then used to
measure similarity between subjects [29]. The principal co-
ordinates analysis of the unweighted Unifrac distances showed
apparent separation between the patient and control groups
(Fig. 1a).
For 16S rRNA-based microbiome studies, it is appropriate to
analyse the taxonomic difference across samples at the genus
level [30]. The differential genera between patients and healthy
controls were identiﬁed using a two-side Wilcoxon rank sum
test and were displayed through a heat map (Fig. 1b). Patients’
samples were signiﬁcantly enriched in Akkermansia, Enterobacterious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 851.e1–851.e9
FIG. 2. Content of bile bacteria in AC patients. (a) Copy numbers
of three bacteria revealed by qPCR. (b) Positive correlation of
Enterobacteriaceae and E. coli content. Hollow triangles represent
subjects. (c) DGGE proﬁles. Bacteria of main lanes were identiﬁed
by DNA sequence analysis (see Materials and Methods).
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were also increased, but not signiﬁcantly (p 0.09). One study
demonstrated that Enterobacteriaceae can be highly enriched in
gut microbiota of gallbladder stones patients [13], which was
also observed in our AC subjects (p < 0.01). For the healthy
controls, Clostridiales, Coprococcus, Coprobacillaceae, Para-
prevotella, Turicibacter and TM7-3 were signiﬁcantly enriched, as
were Faecalibacterium (p 0.08) and Ruminococcus (p 0.08).
Enterobacteriaceae are enriched in bile microbiota of
AC patients
To quantify the bacterial content of the bile samples from AC
patients, qPCR analyses was performed using Enter-
obacteriaceae universal primers and the speciﬁc primers of two
species, Escherichia coli and Clostridium perfringens. The results
showed that Enterobacteriaceae was observed in most (14/16)Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Insamples at a threshold of 10 000 bacteria copies per milliliter of
bile, with copy numbers ranging from 1.06 × 104 to 1.04 × 108
(average 2.33 × 107) (Fig. 2a). The widely distribution and high
enrichment of Enterobacteriaceae in the bile samples were
consistent with those from the gut samples in this study and
with a gallbladder stones study [13]. We further observed that
11 of the 14 Enterobacteriaceae-enriched samples consisted
mainly of E. coli and had close correlation of bacteria copies
(Fig. 2b). On the other hand, C. perfringens was found distrib-
uted in only four samples, and with very low copy numbers
ranging from 1.18 × 104 to 5.68 × 104 (average 3.37 × 104).
DGGE investigations for further precise species information
validated E. coli as the major component of the
Enterobacteriaceae-enriched bile samples. Three other
non–E. coli components—Klebsiella spp., Citrobacter freundii and
Enterobacter cloacae—were also identiﬁed (Fig. 2c). The otherfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 851.e1–851.e9
FIG. 4. Endotoxin level is associated with Enterobacteriaceae content.
Subjects are represented by solid triangles with color codes: red, high
endotoxin level; black, medium endotoxin level; green, low endotoxin
level.
851.e6 Clinical Microbiology and Infection, Volume 21 Number 9, September 2015 CMIEnterobacteriaceae species that frequently occurred in the bile
might be Morganella and Raoultella, as well as Salmonella, sug-
gested in other studies [31].
An interesting question was whether the Enterobacteriaceae
of the gut microbiota and the bile ﬂora could be somehow
connected. To address this, we used qPCR to quantity Enter-
obacteriaceae and E. coli in the faecal and bile samples of these
patients. There were signiﬁcant positive correlations between
the gut and bile for both Enterobacteriaceae (r = 0.91, p 0.001)
and E. coli (r = 0.95, p < 0.001) (Fig. 3). This ﬁnding provided
reliable evidence that the bile pathogens might have originated
from the gut, and it was in agreement with the previous hy-
pothesis [32].
Endotoxin level of AC patients
Endotoxins act as determinants of virulence in Gram-negative
bacteria [33,34] and function to incite systemic inﬂammation
in the host organism [35]. For the 16 bile samples from AC
patients, appreciable endotoxin levels were detected and were
signiﬁcantly associated with the copy numbers of both Enter-
obacteriaceae (odds ratio 4.99, 95% conﬁdence interval
1.21–20.7, p 0.006) and E. coli (odds ratio 2.34, 95% conﬁdence
interval 0.90–6.08, p 0.022). The high/medium endotoxin levels
occurred mostly in the higher Enterobacteriaceae samples
(Fig. 4), leading to 14-fold higher Enterobacteriaceae count in
high/medium endotoxin level samples than the low endotoxin
level samples. The consistency of endotoxin level and insight
from the qPCR data indicated that Enterobacteriaceae might
play a major role in producing endotoxin in the biliary tract of
AC patients.
Guinea pigs infected with E. coli develop cholecystitis
To determine if Enterobacteriaceae is sufﬁcient to promote
cholecystitis, a pathogenic E. coli strain (serotype O124:K72,Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectpathogenic type EIEC) was isolated from an AC patient and
inoculated into guinea pigs by intragastric (n = 1) or rectal
suppository (n = 2) administration. After 30 days of feeding and
daily inoculation (see Material and Methods), the experimental
guinea pigs became inactive, drank less and ate more compared
to the control group (n = 2) (data not show). Anatomic images
and histomorphologic changes are shown in Fig. 5. Anatomy
revealed that animals in the experimental group had dark yel-
low opaque bile, deformed gallbladder and stones compared
with clear and bright yellow bile, and normal gallbladder in the
control group (Fig. 5a). This changes were similar to the gall-
bladder of guinea pigs fed a high-cholesterol diet in a previous
study by Fan et al. [36]. HE staining showed mucosa epithelial
hyperplasia in the gallbladder and higher inﬂammatory cellsFIG. 3. Enterobacteriaceae content in
faecal and bile samples. Subjects are repre-
sented by solid points. Line of best ﬁt is
shown ﬂanked by shadows for 95% conﬁ-
dence interval on both sides.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 851.e1–851.e9
FIG. 5. Anatomic and histomorphologic images of
experimental guinea pigs. (a) Image of morphologic and
anatomic changes of gallbladder of guinea pigs. (A)
Normal gallbladder from a negative control group. (B,
C) Experimental group showing dark yellow opaque bile
as well as deformed gallbladder and stones (arrow).
Minimum division value = 1 mm. (b) Representative
images of gallbladder wall stained with HE; original
magniﬁcation ×20. Gallbladder of experimental group
showed mucosa epithelial hyperplasia with obvious
elongation of mucosal fold into cystic cavity. Mild
inﬂammation was apparent (arrow). (c) Representative
sign of gallbladder epithelial hyperplasia with typical HE
staining. Rokitansky-Aschoff sinus (RAS) (arrow)
appeared in one gallbladder sample of experimental
group, which was treated with rectal suppository con-
taining E. coli (original magniﬁcation ×20). (d) Normal
liver tissue from negative control group (original
magniﬁcation ×10) (A) and experimental group showing
mild edema in liver cells at (B) original magniﬁcation ×20
and (C) original magniﬁcation ×10. There were tiny foci
of phlogocyte inﬁltration in certain parts of liver (ar-
row). (e) Representative images of colon wall stained
with HE. (A) Control group, original magniﬁcation ×10.
Experimental group at (B) original magniﬁcation ×20 and
(C) original magniﬁcation ×10 show experimental group
to have more inﬂammatory cell inﬁltrations in stratum
mucosum (arrow).
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851.e8 Clinical Microbiology and Infection, Volume 21 Number 9, September 2015 CMIinﬁltrations of the liver and colon of the experimental group
animals (Fig. 5b–e), an indication that E. coli inoculation led to
gallbladder and colon inﬂammation. These data suggested that
E. coli infection may have the propensity to cause cholecystitis in
guinea pigs and lead to gut microbiota imbalance.DiscussionEnterobacteriaceae present as the major harmful members in
human symbiotic microbial community [37] and cause a large
amount of physical illnesses, including acute pelvic inﬂammatory
disease, necrotizing enterocolitis and urinary tract infection
[38–41]. Enterobacteriaceae infections are commonly observed
in the gastrointestinal or urinary tract. However, some of these
strains can cause diseases if they contaminate a normally sterile
site such as the body cavities [42]. In the current study, noticeable
enrichment of Enterobacteriaceae in both the gut and bile
microbiota of AC patients was found by using multiple technol-
ogies.We found that, ﬁrstly, the quantities of Enterobacteriaceae
signiﬁcantly correlated with the bile endotoxin levels, and sec-
ondly, a pathogenic E. coli strain isolated from a patient and
inoculated into guinea pigs could promote inﬂammation and
induce morphologic changes in the gallbladder of the animals.
These ﬁndings indicated that Enterobacteriaceae might be the
primary causative organisms of AC. In agreement with our
ﬁndings, other studies have implicated several genera of Enter-
obacteriaceae, including E. coli, Klebsiella pneumonia and Salmo-
nella, to be the main pathogenic bacteria in bile ﬂora [8,43,44].
A strong correlation between the quantities of Enter-
obacteriaceae existing in the gut and bile ﬂora was also found.
According to the data from Almeida et al. [45], E. coli infection
can degrade intestinal barrier and thereby compromise its
integrity. This may permit gut ﬂora to transmit to otherwise
sterile sites and/or systems of the host such as the blood and
biliary circuits. Wu et al. [13] veriﬁed this and reported that
70% of gut bacterial operational taxonomic units from gallstone
patients were detectable in the biliary tract, and injection of
E. coli into the portal vein in rabbits also led to chronic
inﬂammation and stone formation in the gallbladder [46].
Therefore, a hypothesis has arisen from these and other similar
studies that bacteria can be transferred from the gut into the
bile in some way.
A larger amount of Akkermansia was observed in the gut
microbiota of AC patients. A. muciniphila is a mucin degrader
which exists in the human intestinal tract [47] and which is
associated with protecting the mucus lining of healthy intestines
[48]. Nevertheless, the effect of A. muciniphila on patients re-
mains unknown. For the healthy controls, Clostridiales, Cop-
rococcus, Paraprevotella, Faecalibacterium and Ruminococcus,Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectwhich are normal gut microﬂora, were signiﬁcantly enriched.
Coprococcus and Faecalibacterium especially can produce buty-
rate, which is essential for the energy metabolism and normal
development of colonic epithelial cells and therefore play a
protective role in relation to colonic disease [49]. Faecali-
bacterium has also been suggested to protect colonic mucosa
against the development of inﬂammation and could be crucial to
gut homeostasis [50].
This study therefore provides additional insight essential for
the prevention, diagnosis and treatment strategies against AC
and related diseases by controlling the growth of Enter-
obacteriaceae to alleviate the infection. Probiotics and pre-
biotics might be utilized to regulate the intestinal ﬂora to
reduce the incidence of cholecystitis. However, further studies
are needed to test which selected prebiotics or probiotics
could lower the risk of AC.Transparency declarationThis work was ﬁnancially supported by the National Basic
Research Program of China (2012CB518803) and the Research
Fund for the Doctoral Program of Higher Education
(20112105110002). All authors report no conﬂicts of interest
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